| Trial in Adult Subjects With Acute Migraines (NCT03461757) | Pfizer | 2018-02-27 |
| Open Label Safety Study in Acute Treatment of Migraine (NCT03266588) | Pfizer | 2017-08-30 |
| The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination (NCT03194555) | Allodynic Therapeutics, Inc | 2017-08-25 |
| Safety and Efficacy in Adult Subjects With Acute Migraines (NCT03237845) | Pfizer | 2017-07-27 |
| Safety and Efficacy Study in Adult Subjects With Acute Migraines (NCT03235479) | Pfizer | 2017-07-18 |
| Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine (NCT03061734) | Allodynic Therapeutics, Inc | 2017-02-18 |
| An Acute Migraine Factorial Study (NCT06245902) | Allodynic Therapeutics, Inc | 2017-02-18 |
| An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine (NCT02873221) | Allergan | 2016-09-13 |
| Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine (NCT02867709) | Allergan | 2016-08-26 |
| Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine (NCT02828020) | Allergan | 2016-07-22 |
| Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine (NCT02605174) | Eli Lilly and Company | 2016-05-01 |
| Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan (NCT01989936) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1999-01-01 |
| Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo (NCT01986270) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1996-12-01 |
| Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study (NCT01986088) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1996-11-01 |
| Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine (NCT01978496) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1996-07-01 |